We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$864M
AUM Growth
+$54.1M
Cap. Flow
+$8.09M
Cap. Flow %
0.94%
Top 10 Hldgs %
50.84%
Holding
197
New
11
Increased
61
Reduced
63
Closed
13
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHB icon
1
Schwab US Broad Market ETF
SCHB
$44.7B
$104M 12.04%
6,519,675
+114,345
+2% +$1.79M
SCHF icon
2
Schwab International Equity ETF
SCHF
$69.3B
$63.8M 7.38%
3,665,832
+170,846
+5% +$2.93M
FNDF icon
3
Schwab Fundamental International Large Company Index ETF
FNDF
$26B
$44.2M 5.11%
1,412,810
+81,211
+6% +$2.51M
GSIE icon
4
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.12B
$39.4M 4.57%
1,280,207
-13,827
-1% -$421K
FNDX icon
5
Schwab Fundamental US Large Company Index ETF
FNDX
$27.6B
$38M 4.4%
2,078,370
+356,646
+21% +$6.54M
PRF icon
6
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
$34.2M 3.96%
1,091,590
-9,465
-0.9% -$300K
SPDW icon
7
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
$31.8M 3.68%
989,015
-15,372
-2% -$485K
VTEB icon
8
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.6B
$29.3M 3.39%
577,525
-3,464
-0.6% -$174K
AVDV icon
9
Avantis International Small Cap Value ETF
AVDV
$20.3B
$28M 3.24%
477,997
+20,177
+4% +$1.18M
INTF icon
10
iShares International Equity Factor ETF
INTF
$3.75B
$26.5M 3.07%
1,000,009
-29,858
-3% -$777K
GSLC icon
11
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
$25.9M 3%
318,936
-10,125
-3% -$803K
FNDB icon
12
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.49B
$25.5M 2.95%
1,412,442
-8,937
-0.6% -$162K
SPTM icon
13
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
$19.5M 2.26%
386,563
-8,127
-2% -$401K
VEU icon
14
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
$18.1M 2.09%
337,902
-1,525
-0.4% -$80.8K
VWO icon
15
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$17.6M 2.04%
435,136
+17,439
+4% +$711K
AAPL icon
16
Apple
AAPL
$4.67T
$16.6M 1.92%
100,543
-861
-0.8% -$127K
XLK icon
17
State Street Technology Select Sector SPDR ETF
XLK
$121B
$16.2M 1.88%
214,568
-2,442
-1% -$168K
FNDA icon
18
Schwab Fundamental US Small Company Index ETF
FNDA
$9.15B
$16.1M 1.86%
660,518
+16,636
+3% +$415K
VGT icon
19
Vanguard Information Technology ETF
VGT
$147B
$13.4M 1.55%
278,192
+16,016
+6% +$708K
AVUS icon
20
Avantis US Equity ETF
AVUS
$14.5B
$12.2M 1.41%
171,912
+9,351
+6% +$662K
PRFZ icon
21
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.83B
$11.2M 1.3%
340,180
-1,075
-0.3% -$36.2K
DISV icon
22
Dimensional International Small Cap Value ETF
DISV
$5.25B
$10M 1.16%
420,628
-6,400
-1% -$152K
XLV icon
23
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$9.31M 1.08%
71,882
-2,195
-3% -$287K
VHT icon
24
Vanguard Health Care ETF
VHT
$19.3B
$7.4M 0.86%
31,047
+1,319
+4% +$317K
PXF icon
25
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.99B
$6.92M 0.8%
157,028
-1,411
-0.9% -$62.2K

Similar funds

Callan Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Callan Capital held 197 positions worth $864M, up 6.7% from $810M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Callan Capital's Q1 2023 filing shows 11 new, 61 increased, 63 reduced and 13 closed positions. Its largest new stake was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M. The largest sale was Jazz Pharmaceuticals, an estimated $2.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Technology and Financials.

  • Callan Capital's largest Q1 2023 buy was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M.
  • Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q1 2023, an estimated $6.54M increase.
  • Callan Capital's biggest Q1 2023 reduction was JPMorgan Ultra-Short Municipal Income ETF, cutting an estimated $2.27M.
  • Callan Capital fully exited Jazz Pharmaceuticals in Q1 2023, selling an estimated $2.53M.
  • Callan Capital's ten largest holdings make up 51% of its $864M portfolio in Q1 2023.
  • Callan Capital opened 11 new positions and closed 13 in Q1 2023.
  • Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $864M.

Based on Callan Capital's 13F filing for Q1 2023, filed 9 May 2023.